Virios Therapeutics (VIRI) Reports Q2 Loss of $0.51/sh

Virios Therapeutics (NASDAQ: VIRI) reported Q2 EPS of ($0.51), versus ($0.14) reported last year.

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Rex American Resources Corp. (REX) Tops Q2 EPS by 64c
• BofA downgrades Amrize to underperform, cuts price target on slower growth outlook